Here’s what you should know:
1. Exact reports its earnings Aug. 1.
2. The company’s stock has jumped 23 percent since the start of the year.
3. Six analysts have awarded Exact a “buy” rating.
4. Baird’s Catherine Schulte said, “We believe [Exact] is positioned to deliver on/exceed its 2018 guidance, with marketing campaigns, salesforce expansion and health system penetration all potentially helping [the second half] and beyond.” She also predicted Exact will hit around $1 billion in revenues in two years.
More articles on gastroenterology:
Key Surgical, ModMed & more — 3 GI company key notes
10 things to know about ASC coding audits
GI residents earn over $64K — Here’s which specialties rake in more
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.